Current Tools and Methods in Molecular Dynamics (MD) Simulations for Drug Design

被引:72
|
作者
Hernandez-Rodriguez, Maricarmen [1 ]
Rosales-Hernandez, Martha C. [1 ]
Mendieta-Wejebe, Jessica E. [1 ]
Martinez-Archundia, Marlet [2 ]
Correa Basurto, Jose [2 ]
机构
[1] Inst Politecn Nacl, Lab Biofis & Biocatalisis, Escuela Super Med, Ciudad De Mexico, Mexico
[2] Inst Politecn Nacl, Lab Modelado Mol & Diseno Farmacos, Escuela Super Med, Ciudad De Mexico, Mexico
关键词
Drug design; Molecular Dynamics simulations; protein motions; drug discovery; docking studies; sampling several protein conformations; PROTEIN-LIGAND BINDING; FREE-ENERGY; FORCE-FIELD; CONFORMATIONAL ENSEMBLES; COMPUTATIONAL METHODS; NMR STRUCTURES; INHIBITORS; REFINEMENT; DOCKING; DISCOVERY;
D O I
10.2174/0929867323666160530144742
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular Dynamics (MD) simulations is a computational method that employs Newton's laws to evaluate the motions of water, ions, small molecules, and macromolecules or more complex systems, for example, whole viruses, to reproduce the behavior of the biological environment, including water molecules and lipid membranes. Specifically, structural motions, such as those that are dependent of the temperature and solute/solvent are very important to study the recognition pattern of ligandprotein or protein-protein complexes, in that sense, MD simulations are very useful because these motions can be modeled using this methodology. Furthermore, MD simulations for drug design provide insights into the structural cavities required to design novel structures with higher affinity to the target. Also, the employment of MD simulations to drug design can help to refine the three-dimensional (3D) structure of targets in order to obtain a better sampling of the binding poses and more reliable affinity values with better structural advantages, because they incorporate some biological conditions that include structural motions compared to traditional docking procedures. This work analyzes the concepts and applicability of MD simulations for drug design because molecular structural motions are considered, and these help to identify hot spots, decipher structural details in the reported protein sites, as well as to eliminate sites that could be structural artifacts which could be originated from the structural characterization conditions from MD. Moreover, better free energy values for protein ligand recognition can also be obtained, and these can be validated under experimental procedures due to the robustness of the MD simulation methods.
引用
收藏
页码:3909 / 3924
页数:16
相关论文
共 50 条
  • [1] Molecular dynamics simulations: A tool for drug design
    Rognan, D
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1998, 9-11 : 181 - 209
  • [2] Prediction of drug-packaging interactions via molecular dynamics (MD) simulations
    Feenstra, Peter
    Brunsteiner, Michael
    Khinast, Johannes
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 431 (1-2) : 26 - 32
  • [3] APPLICATION OF MOLECULAR-DYNAMICS (MD) AND FREE-ENERGY SIMULATIONS (FES) TO PROBLEMS OF PROTEIN AND DRUG DESIGN
    TROPSHA, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 93 - COMP
  • [4] MOLECULAR-DYNAMICS (MD) SIMULATIONS FOR POLYMERS
    KREMER, K
    GREST, GS
    JOURNAL OF PHYSICS-CONDENSED MATTER, 1990, 2 : SA295 - SA298
  • [5] Discussion on molecular dynamics (MD) simulations of the asphalt materials
    Yao, Hui
    Liu, Junfu
    Xu, Mei
    Ji, Jie
    Dai, Qingli
    You, Zhanping
    ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2022, 299
  • [6] Discussion on molecular dynamics (MD) simulations of the asphalt materials
    Yao, Hui
    Liu, Junfu
    Xu, Mei
    Ji, Jie
    Dai, Qingli
    You, Zhanping
    Advances in Colloid and Interface Science, 2022, 299
  • [7] Molecular dynamics simulations of proteins and peptides: From folding to drug design
    Morra, Giulia
    Meli, Massimiliano
    Colombo, Giorgio
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2008, 9 (02) : 181 - 196
  • [8] Application of Drug-Perturbed Essential Dynamics/Molecular Dynamics (ED/MD) to Virtual Screening and Rational Drug Design
    Chaudhuri, Rima
    Carrillo, Oliver
    Laughton, Charles Anthony
    Orozco, Modesto
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (07) : 2204 - 2214
  • [9] Molecular dynamics simulations and drug discovery
    Jacob D Durrant
    J Andrew McCammon
    BMC Biology, 9
  • [10] Molecular Dynamics Simulations in Drug Discovery
    Nascimento, Igor Jose dos Santos
    de Moura, Ricardo Olimpio
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (11) : 1061 - 1062